Pharmaceuticals in South Korea
Summary
Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The South Korean pharmaceuticals market recorded revenues of $27.0 billion in 2024, representing a compound annual growth rate (CAGR) of 4.8% between 2019 and 2024.
- The cardiovascular disease drugs segment accounted for the market's largest proportion in 2024, with total revenues of $4.4 billion, equivalent to 16.2% of the market's overall value.
- The South Korean pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 6.0%.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Korea
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea
- Leading company profiles reveal details of key pharmaceuticals market players? global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the South Korea pharmaceuticals market by value in 2024?
- What will be the size of the South Korea pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the South Korea pharmaceuticals market?
- How has the market performed over the last five years?
- How large is South Korea?s pharmaceuticals market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?
8 COMPANY PROFILES
8.1. Chong Kun Dang Pharmaceutical Corp.
8.2. Hanmi Pharmaceuticals Co Ltd
8.3. Celltrion Inc
8.4. Yuhan Corp
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?
8 COMPANY PROFILES
8.1. Chong Kun Dang Pharmaceutical Corp.
8.2. Hanmi Pharmaceuticals Co Ltd
8.3. Celltrion Inc
8.4. Yuhan Corp
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: South Korea pharmaceuticals market value: $ million, 2019-24
Table 2: South Korea pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: South Korea pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: South Korea pharmaceuticals market geography segmentation: $ million, 2024
Table 5: South Korea pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Chong Kun Dang Pharmaceutical Corp.: Key Facts
Table 7: Chong Kun Dang Pharmaceutical Corp.: Annual Financial Ratios
Table 8: Chong Kun Dang Pharmaceutical Corp.: Key Employees
Table 9: Hanmi Pharmaceuticals Co Ltd: Key Facts
Table 10: Hanmi Pharmaceuticals Co Ltd: Annual Financial Ratios
Table 11: Hanmi Pharmaceuticals Co Ltd: Key Employees
Table 12: Celltrion Inc: Key Facts
Table 13: Celltrion Inc: Annual Financial Ratios
Table 14: Celltrion Inc: Key Employees
Table 15: Yuhan Corp: Key Facts
Table 16: Yuhan Corp: Annual Financial Ratios
Table 17: Yuhan Corp: Key Employees
Table 18: South Korea Exchange Rate, 2019-24
Table 1: South Korea pharmaceuticals market value: $ million, 2019-24
Table 2: South Korea pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: South Korea pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: South Korea pharmaceuticals market geography segmentation: $ million, 2024
Table 5: South Korea pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Chong Kun Dang Pharmaceutical Corp.: Key Facts
Table 7: Chong Kun Dang Pharmaceutical Corp.: Annual Financial Ratios
Table 8: Chong Kun Dang Pharmaceutical Corp.: Key Employees
Table 9: Hanmi Pharmaceuticals Co Ltd: Key Facts
Table 10: Hanmi Pharmaceuticals Co Ltd: Annual Financial Ratios
Table 11: Hanmi Pharmaceuticals Co Ltd: Key Employees
Table 12: Celltrion Inc: Key Facts
Table 13: Celltrion Inc: Annual Financial Ratios
Table 14: Celltrion Inc: Key Employees
Table 15: Yuhan Corp: Key Facts
Table 16: Yuhan Corp: Annual Financial Ratios
Table 17: Yuhan Corp: Key Employees
Table 18: South Korea Exchange Rate, 2019-24
LIST OF FIGURES
Figure 1: South Korea pharmaceuticals market value: $ million, 2019-24
Figure 2: South Korea pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: South Korea pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: South Korea pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in South Korea, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in South Korea, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in South Korea, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2024
Figure 1: South Korea pharmaceuticals market value: $ million, 2019-24
Figure 2: South Korea pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: South Korea pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: South Korea pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in South Korea, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in South Korea, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in South Korea, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2024
